Company intelligence / Profile preview
Nora Therapeutics, Inc.
Palo Alto, California, United Statesprnewswire.com ↗
- Ownership
- Private
- Employees
- ~8
- Development stage
- Phase 2
01
Overview
Nora Therapeutics was a privately-held biotechnology company focused on developing novel therapeutics for reproductive medicine, specifically targeting infertility due to failed IVF cycles and recurrent pregnancy loss. Its lead compound, NT100—a biologic similar to naturally occurring proteins in the female reproductive tract—was designed to optimize maternal-fetal immune tolerance. The company advanced NT100 into two main Phase 2 clinical trials (THRIVE-IVF for failed IVF cycles and RESPONSE for unexplained recurrent pregnancy loss). No commercial products were launched before the company became inactive around or after March 2018. Clinical results have not been published in detail.
- Therapeutic areas
- Women's Health
- Modalities
- Biologic agent (proprietary G-CSF/granulocyte-colony stimulating factor)synthetic peptide
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Investors included Novo A/S/Novo Ventures, Burrill & Company, Prospect Venture Partners, Rho Ventures, Vivo Capital
Beyond the preview
Go deeper on Nora Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nora Therapeutics, Inc..